EUVIMEDEUVIMED entdecken
Crossref

A Bioactive Benzimidazole‐Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED–EZH2 Interaction

Shasha Cheng, Jian Li, Ying-Qi Song, Shaozhen Jing, Yi-Xuan Lan, Ling Wang, Daniel Shiu-Hin Chan, Chun-Yuen Wong, Chunquan Sheng, Wanhe Wang, Hui-Min David Wang, Chung-Hang Leung iD

Small · 2025

DOI: 10.1002/smll.202405771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Shasha Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Epigenesis, Genetic, Iridium, Polycomb Repressive Complex 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: the University of Macau, University of Macau Development Foundation, Macau SAR, China, State Key Laboratory of Quality Research in Chinese Medicine, the University of Macau, Macau SAR, China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic regulation plays a fundamental role in controlling gene expression and maintaining cellular identity. Among epigenetic processes, the translocation of methyltransferases is critical for the modification of chromatin structure and transcriptional activity. The regulation of these translocation events and the mechanisms involved are complex, yet critical for understanding and manipulating epigenetic states. Therefore, novel strategies are required for detecting and visualizing the movement and interaction of methyltransferases within cells. Using enhancer of zeste homolog 2 (EZH2) methyltransferase as an example, a bifunctional compound capable of both monitoring and disrupting its translocation process is developed by targeting the protein–protein interaction (PPI) between embryonic ectoderm development (EED) and EZH2. The Ir(III) complex 1 bound enthalpically to EED and effectively inhibited the methyltransferase activity of EZH2. Moreover, disruption of the EED–EZH2 PPI led to increased transcriptional activity of P21 and P27 , resulting in the suppression of triple‐negative breast cancer (TNBC) cell proliferation. Excitingly, 1 suppressed tumor metastasis in a TNBC mouse model in vivo . To our knowledge, complex 1 is the first metal‐based bifunctional therapeutic agent designed to probe and inhibit the EED–EZH2 PPI, highlighting the feasibility and significance of using metal complexes to monitor and influence methyltransferase translocations for therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticIridiumPolycomb Repressive Complex 2HumansAnimalsCell Line, TumorMiceCell ProliferationProtein Binding

Stichwörter der Autor:innen

EED–EZH2inhibitorprotein–protein interactiontriple‐negative breast cancer

Substanzen

Enhancer of Zeste Homolog 2 ProteinIridiumPolycomb Repressive Complex 2EED protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.
  • College of Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
  • Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
  • Institute of Medical Research, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, Shaanxi, 710072, China.
  • Research & Development Institute of Northwestern Polytechnical University in Shenzhen, 45 South Gaoxin Road, Shenzhen, 518057, China.
  • Graduate Institute of Biomedical Engineering, National Chung Hsing University, Taichung, 402, Taiwan.

ORCID-Profile: Chung-Hang Leung

Förderung

  • the University of Macau, University of Macau Development Foundation, Macau SAR, China
  • State Key Laboratory of Quality Research in Chinese Medicine, the University of Macau, Macau SAR, China
  • National Natural Science Foundation of China
  • Key Research and Development Program of Shaanxi
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • Innovation Capability Support Program of Shaanxi
  • Hainan Province Science and Technology Special Fund

Zitieren

APA

Cheng, S., Li, J., Song, Y. Q., Jing, S., Lan, Y. X., Wang, L., Chan, D. S., Wong, C. Y., Sheng, C., Wang, W., Wang, H. D., & Leung, C. H. (2025). A Bioactive Benzimidazole‐Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED–EZH2 Interaction. Small. https://doi.org/10.1002/smll.202405771

Vancouver

Cheng S, Li J, Song YQ, Jing S, Lan YX, Wang L, et al. A Bioactive Benzimidazole‐Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED–EZH2 Interaction. Small. 2025. doi:10.1002/smll.202405771

BibTeX
@article{Cheng2025,
  author = {Cheng, Shasha and Li, Jian and Song, Ying-Qi and Jing, Shaozhen and Lan, Yi-Xuan and Wang, Ling and Chan, Daniel Shiu-Hin and Wong, Chun-Yuen and Sheng, Chunquan and Wang, Wanhe and Wang, Hui-Min David and Leung, Chung-Hang},
  title = {A Bioactive Benzimidazole‐Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED–EZH2 Interaction},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202405771}
}
Kostenlos starten →